Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Completed4
Recruiting2
Terminated2
Other1

Role Distribution

Principal Investigator9
PI Rate100%

Activity Timeline

Clinical Trials (9)

NCT05273138Recruiting
Analysis of Dermal Fibroblasts and Immune Cells During Systemic Sclerosis
Systemic Sclerosis
PrincipalinvestigatorStart date: 2022-06-08
NCT04746313Completed
Prevalence of Hyperprolactinemia in Systemic Scleroderma
HyperprolactinemiaSclerodermaSclerosis, Systemic
PrincipalinvestigatorStart date: 2021-03-01
NCT04334031Not ApplicableRecruiting
Deployment o the Multidisciplinary Prospective Cohort Imminent
AngioedemaAtopic DermatitisBehçet Disease+6 more
PrincipalinvestigatorStart date: 2020-07-20
NCT04178616Not ApplicableTerminated
Assessment of the Prevalence of Olfactory Disorders in Systemic Scleroderma
Olfactory DisordersScleroderma
PrincipalinvestigatorStart date: 2019-12-31
NCT03559465Not ApplicableCompleted
Profibrosing Role of B Lymphocytes in Patients With Systemic Sclerosis.
Scleroderma, Systemic
PrincipalinvestigatorStart date: 2018-10-29
NCT03370627Not ApplicableCompleted
Effect of Anti-CD303 Antibodies in Autoimmune Diseases
Immune Disease
PrincipalinvestigatorStart date: 2017-12-20

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (9)

Showing 9 of 9 trials

NCT05273138PrincipalInvestigator

Analysis of Dermal Fibroblasts and Immune Cells During Systemic Sclerosis

Systemic Sclerosis
Recruiting
NCT04963634PrincipalInvestigator

Research of Biomarkers Associated With the Diagnosis and Severity of Bradykinin Angioedema

Angio Edema
Terminated
NCT04746313PrincipalInvestigator

Prevalence of Hyperprolactinemia in Systemic Scleroderma

HyperprolactinemiaSclerodermaSclerosis, Systemic
Completed
NCT04334031Not ApplicablePrincipalInvestigator

Deployment o the Multidisciplinary Prospective Cohort Imminent

AngioedemaAtopic DermatitisBehçet Disease+6 more
Recruiting
NCT04178616Not ApplicablePrincipalInvestigator

Assessment of the Prevalence of Olfactory Disorders in Systemic Scleroderma

Olfactory DisordersScleroderma
Terminated
NCT03559465Not ApplicablePrincipalInvestigator

Profibrosing Role of B Lymphocytes in Patients With Systemic Sclerosis.

Scleroderma, Systemic
Completed
NCT03271333PrincipalInvestigator

Description of the Functional Evolution of Diffuse Infiltrating Pneumonia Associated With Systemic Scleroderma.

Systemic Sclerosis
Completed
NCT03370627Not ApplicablePrincipalInvestigator

Effect of Anti-CD303 Antibodies in Autoimmune Diseases

Immune Disease
Completed
NCT04986514PrincipalInvestigator

Implementation of a Biological Sample Collection in Systemic Sclerosis Patients

Systemic Sclerosis
Withdrawn

All 9 trials loaded